REPORT ID 2396

United States Neuromodulation Devices Market Report 2017

Publish Date
8-Dec-17
Pages
103
Format
Electronic (PDF)

In this report, the United States Neuromodulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Neuromodulation Devices in these regions, from 2012 to 2022 (forecast).

United States Neuromodulation Devices market competition by top manufacturers/players, with Neuromodulation Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Medtronic
    Boston Scientific Corporation
    St.Jude Medical
    Synapse Biomedical
    Nevro
    Neurosigma
    Neuropace
    Neuronetics
    Cyberonics
    BioControl Medical

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Deep Brain Stimulation (DBS) Systems
    Spinal Cord Stimulator (SCS) Systems
    Diaphragm Pacing System (DPS)
    Respiratory Electrical Stimulation (RES)
    Vagus Nerve Stimulation (VNS)
    Gastric Electrical Stimulation (GES)
    Transcranial Magnetic Stimulation (TMS)
    Transcutaneous Electrical Nerve Stimulation (TENS)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Chronic Pain
    Parkinson's Disease
    Urine Incontinence
    Epilepsy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Neuromodulation Devices Market Report 2017
1 Neuromodulation Devices Overview
    1.1 Product Overview and Scope of Neuromodulation Devices
    1.2 Classification of Neuromodulation Devices by Product Category
        1.2.1 United States Neuromodulation Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Neuromodulation Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Deep Brain Stimulation (DBS) Systems
        1.2.4 Spinal Cord Stimulator (SCS) Systems
        1.2.5 Diaphragm Pacing System (DPS)
        1.2.6 Respiratory Electrical Stimulation (RES)
        1.2.7 Vagus Nerve Stimulation (VNS)
        1.2.8 Gastric Electrical Stimulation (GES)
        1.2.9 Transcranial Magnetic Stimulation (TMS)
        1.2.10 Transcutaneous Electrical Nerve Stimulation (TENS)
    1.3 United States Neuromodulation Devices Market by Application/End Users
        1.3.1 United States Neuromodulation Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Chronic Pain
        1.3.3 Parkinson's Disease
        1.3.4 Urine Incontinence
        1.3.5 Epilepsy
        1.3.6 Others
    1.4 United States Neuromodulation Devices Market by Region
        1.4.1 United States Neuromodulation Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.3 Southwest Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.5 New England Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.6 The South Neuromodulation Devices Status and Prospect (2012-2022)
        1.4.7 The Midwest Neuromodulation Devices Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Neuromodulation Devices (2012-2022)
        1.5.1 United States Neuromodulation Devices Sales and Growth Rate (2012-2022)
        1.5.2 United States Neuromodulation Devices Revenue and Growth Rate (2012-2022)

2 United States Neuromodulation Devices Market Competition by Players/Suppliers
    2.1 United States Neuromodulation Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Neuromodulation Devices Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Neuromodulation Devices Average Price by Players/Suppliers (2012-2017)
    2.4 United States Neuromodulation Devices Market Competitive Situation and Trends
        2.4.1 United States Neuromodulation Devices Market Concentration Rate
        2.4.2 United States Neuromodulation Devices Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Neuromodulation Devices Manufacturing Base Distribution, Sales Area, Product Type

3 United States Neuromodulation Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Neuromodulation Devices Sales and Market Share by Region (2012-2017)
    3.2 United States Neuromodulation Devices Revenue and Market Share by Region (2012-2017)
    3.3 United States Neuromodulation Devices Price by Region (2012-2017)

4 United States Neuromodulation Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Neuromodulation Devices Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Neuromodulation Devices Revenue and Market Share by Type (2012-2017)
    4.3 United States Neuromodulation Devices Price by Type (2012-2017)
    4.4 United States Neuromodulation Devices Sales Growth Rate by Type (2012-2017)

5 United States Neuromodulation Devices Sales (Volume) by Application (2012-2017)
    5.1 United States Neuromodulation Devices Sales and Market Share by Application (2012-2017)
    5.2 United States Neuromodulation Devices Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Neuromodulation Devices Players/Suppliers Profiles and Sales Data
    6.1 Medtronic
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Neuromodulation Devices Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boston Scientific Corporation
        6.2.2 Neuromodulation Devices Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 St.Jude Medical
        6.3.2 Neuromodulation Devices Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 St.Jude Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Synapse Biomedical
        6.4.2 Neuromodulation Devices Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Nevro
        6.5.2 Neuromodulation Devices Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Neurosigma
        6.6.2 Neuromodulation Devices Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Neurosigma Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Neuropace
        6.7.2 Neuromodulation Devices Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Neuropace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Neuronetics
        6.8.2 Neuromodulation Devices Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Neuronetics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Cyberonics
        6.9.2 Neuromodulation Devices Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Cyberonics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 BioControl Medical
        6.10.2 Neuromodulation Devices Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Neuromodulation Devices Manufacturing Cost Analysis
    7.1 Neuromodulation Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Neuromodulation Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Neuromodulation Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Neuromodulation Devices Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Neuromodulation Devices Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Neuromodulation Devices Sales Volume Forecast by Type (2017-2022)
    11.3 United States Neuromodulation Devices Sales Volume Forecast by Application (2017-2022)
    11.4 United States Neuromodulation Devices Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer